Comment on “Multiplex B Cell Characterization in Blood, Lymph Nodes, and Tumors from Patients with Malignancies”
暂无分享,去创建一个
[1] O. Winqvist,et al. Multiplex B Cell Characterization in Blood, Lymph Nodes, and Tumors from Patients with Malignancies , 2013, The Journal of Immunology.
[2] K. Becker,et al. Cancer-Produced Metabolites of 5-Lipoxygenase Induce Tumor-Evoked Regulatory B Cells via Peroxisome Proliferator–Activated Receptor α , 2013, The Journal of Immunology.
[3] L. Holmberg,et al. A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin κ C as a Compatible Prognostic Marker in Human Solid Tumors , 2012, Clinical Cancer Research.
[4] R. Wersto,et al. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells. , 2011, Cancer research.
[5] W. Pickl,et al. Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia. , 2011, Blood.
[6] E. S. St. Clair,et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. , 2011, Blood.
[7] B. Nelson,et al. CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes , 2010, The Journal of Immunology.
[8] D. Isenberg,et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. , 2010, Immunity.
[9] K. Flaherty,et al. Collapse of the CD27+ B-Cell Compartment Associated with Systemic Plasmacytosis in Patients with Advanced Melanoma and Other Cancers , 2009, Clinical Cancer Research.
[10] K. Flaherty,et al. Collapse of the CD 27 + B-Cell Compartment Associated with Systemic Plasmacytosis in Patients with Advanced Melanoma and Other Cancers , 2009 .
[11] K. Warnatz,et al. Flowcytometric phenotyping of common variable immunodeficiency , 2008, Cytometry. Part B, Clinical cytometry.